Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development

Controlled Human Infection to Speed Up SARS-CoV-2 Vaccine Development

Bibliographic Details
Main Authors:	Marc Baay, Pieter Neels
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Immunology
Subjects:	coronavirus vaccine development controlled human infection (CHI) human challenge ethics
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.658783/full

Similar Items

Prioritizing second-generation SARS-CoV-2 vaccines through low-dosage challenge studies
by: Bastian Steuwer, et al.
Published: (2021-04-01)

SARS-CoV-2: overview of immune response, insights into vaccine platforms and their challenges
by: Balram Ji Omar, et al.
Published: (2022-05-01)

In silico design of multiepitope vaccine candidate against SARS CoV and CoV2
by: Krupanidhi Sreerama
Published: (2020-12-01)

An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen
by: Xinling Wang, et al.
Published: (2023-12-01)

Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward
by: Xue-Lian Zhao, et al.
Published: (2023-09-01)

Efficacy and safety of four COVID-19 vaccines in preventing SARS-CoV-2 infection: A rapid review
by: Lina Sofía Morón-Duarte, et al.
Published: (2022-10-01)

The Barriers, Challenges, and Strategies of COVID-19 (SARS-CoV-2) Vaccine Acceptance: A Concurrent Mixed-Method Study in Tehran City, Iran
by: Hamid Reza Khankeh, et al.
Published: (2021-10-01)

The role of public involvement in the design of the first SARS-CoV-2 human challenge study during an evolving pandemic
by: Maria Piggin, et al.
Published: (2022-12-01)

Human Challenge Trials for a COVID-19 Vaccine
by: Victor Chidi Wolemonwu
Published: (2020-08-01)

Immunoinformatics Identification of the Conserved and Cross-Reactive T-Cell Epitopes of SARS-CoV-2 with Human Common Cold Coronaviruses, SARS-CoV, MERS-CoV and Live Attenuated Vaccines Presented by HLA Alleles of Indonesian Population
by: Marsia Gustiananda, et al.
Published: (2022-10-01)

Public attitudes to a human challenge study with SARS-CoV-2: a mixed-methods study [version 1; peer review: 2 approved]
by: Michael Bahrami-Hessari, et al.
Published: (2022-02-01)

Multi-Subunit SARS-CoV-2 Vaccine Design Using Evolutionarily Conserved T- and B- Cell Epitopes
by: Burkitkan Akbay, et al.
Published: (2021-06-01)

Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection
by: Bolutife Fakoya, et al.
Published: (2022-04-01)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023-03-01)

Prospects for mucosal vaccine: shutting the door on SARS-CoV-2
by: Rajat Mudgal, et al.
Published: (2020-12-01)

Epidemiology of Non-SARS-CoV2 Human Coronaviruses (HCoVs) in People Presenting with Influenza-like Illness (ILI) or Severe Acute Respiratory Infections (SARI) in Senegal from 2012 to 2020
by: Modeste Name Faye, et al.
Published: (2022-12-01)

An Update on Complications Associated with SARS-CoV-2 Infection and COVID-19 Vaccination
by: Purvita Chowdhury, et al.
Published: (2022-09-01)

Opinions, Attitudes and Factors Related to SARS-CoV-2 Vaccine Uptake in Eight South American Countries
by: Analía Urueña, et al.
Published: (2023-10-01)

Chinese parents’ intentions to vaccinate their children against SARS-CoV-2 infection and vaccine preferences
by: Yulan Lin, et al.
Published: (2021-12-01)

Accurately prevent SARS-CoV-2 infections based on the basic principles of infectious disease prevention and control
by: MAO Qing
Published: (2022-01-01)

Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge
by: Elizabeth Gabitzsch, et al.
Published: (2021-09-01)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
by: Arne Søraas, et al.
Published: (2022-09-01)

Are higher antibody levels against seasonal human coronaviruses associated with a more robust humoral immune response after SARS-CoV-2 vaccination?
by: Michael Asamoah-Boaheng, et al.
Published: (2022-09-01)

Explaining Philosophical Relationship Between Human and Technology with Emphasis on Ethics
by: Mehrban Hadi Peykani, et al.
Published: (2018-03-01)

Vaccines and Therapies in Development for SARS-CoV-2 Infections
by: David Wu, et al.
Published: (2020-06-01)

Effectiveness of Vaccination against SARS-CoV-2 Infection in the Pre-Delta Era: A Systematic Review and Meta-Analysis
by: Angela Meggiolaro, et al.
Published: (2022-01-01)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Mohamed Moubarak, et al.
Published: (2021-07-01)

Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
by: Frontiers Production Office
Published: (2023-07-01)

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
by: Cielo García-Montero, et al.
Published: (2021-04-01)

Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot
by: Laura Thümmler, et al.
Published: (2021-08-01)

SARS-CoV-2 variants in severely symptomatic and deceased persons who had been vaccinated against COVID-19 in São Paulo, Brazil
by: Karoline Rodrigues Campos, et al.
Published: (2021-10-01)

Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine
by: Laura M. Kasman
Published: (2022-09-01)

Transmission of SARS-CoV-2, Required Developments in Research and Associated Public Health Concerns
by: Suliman Khan, et al.
Published: (2020-06-01)

Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
by: Jiahua He, et al.
Published: (2020-04-01)

New variants of SARS-CoV-2, vaccine immune response and the Brazilian reality
by: Marileia Chaves Andrade, et al.
Published: (2021-12-01)

Coronavirus (SARS-CoV-2): a systematic review for potential vaccines
by: Mihir Bhatta, et al.
Published: (2022-01-01)

SARS-CoV-2 vaccine candidates in rapid development
by: Lifeng Li, et al.
Published: (2021-03-01)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
by: Priyal Mistry, et al.
Published: (2022-01-01)

Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2
by: Edris Shirvani, et al.
Published: (2020-07-01)

Vaccine hesitancy for coronavirus SARS-CoV-2 in Varanasi India
by: Utkarsh Srivastava, et al.
Published: (2022-10-01)